Jay Wimalasena

University of Tennessee Medical Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.0kcitations69works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(18), Cancer-related Molecular Pathways(16), Reproductive Biology and Fertility(11), Reproductive Physiology in Livestock(8), Pregnancy and preeclampsia studies(5)

Publications69 total

BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion
Experimental Cell Research·2014· 33 citedOpen Access
Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate
Journal of Cancer Research and Clinical Oncology·2012· 49 citedOpen Access
Adipocytes from obese subjects increase NF‐kB activation in invasive breast cancer cells
The FASEB Journal·2012
P1-02-11: The BCL2 Antagonist of Death, BAD Is Down-Regulated in Breast Cancer and Inhibits Cancer Cell Invasion.
Cancer Research·2011· 1 cited
Breast cancer and adipose cell interactions and modulation by polyunsaturated fatty acids
The FASEB Journal·2011
Abstract 3111: Normal breast epithelial architecture and breast-cancer cell metabolism are altered by adipocytes and inflammatory fatty acids: Implications for postmenopausal breast cancer
Cancer Research·2011
Breast Cancer and Obesity:molecular interactions between adipocytes and cancer cells
The FASEB Journal·2011
Abstract P4-05-01: Molecular Interactions between Human Adipocytes and Breast Cancer Cells May Underline Increased Breast Cancer Incidence in Obese Postmenopausal Women
Cancer Research·2010
Abstract 4591: Estrogen receptor beta controls a wide variety of functions in breast cancer cells
Cancer Research·2010
Abstract 1046: BAD is a multifunctional protein in breast cancer cells
Cancer Research·2010· 1 cited
The antitumorgenic actions of estrogen receptor beta in breast cancer cells.
Cancer Research·2009
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer
Gynecologic Oncology·2008· 27 citedOpen Access
Breast Cancer Cell Proliferation Is Inhibited by BAD
Journal of Biological Chemistry·2007· 33 citedOpen Access
Luteinizing hormone receptor mediates neuronal pregnenolone production via up‐regulation of steroidogenic acute regulatory protein expression
Journal of Neurochemistry·2006· 46 cited
Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity
Cancer Chemotherapy and Pharmacology·2006· 35 cited
Activating Transcription Factor 3 and Early Growth Response 1 Are the Novel Targets of LY294002 in a Phosphatidylinositol 3-Kinase–Independent Pathway
Cancer Research·2006· 80 citedOpen Access
Phospho BAD decreases breast cancer cell proliferation by inhibiting c-jun activation of the CRE in cyclin D1
Cancer Research·2005· 1 cited
Oogenesis in Adult Mammals, Including Humans: A Review
Endocrine·2005· 94 cited
HES-1 inhibits 17β-estradiol and heregulin-β1-mediated upregulation of E2F-1
Oncogene·2004· 62 cited
Estradiol Abrogates Apoptosis in Breast Cancer Cells through Inactivation of BAD: Ras-dependent Nongenomic Pathways Requiring Signaling through ERK and Akt
Molecular Biology of the Cell·2004· 149 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

James S. Foster(20), Antonín Bukovský(18), Michael R. Caudle(10), Jeffrey Keenan(9), Donald C. Henley(6), M. R. Caudle(6), Stuart E. Van Meter(6), Shamila Ahamed(5), Romaine I. Fernando(5), Robert F. Elder(5), Anders Ström(4), Maria Cekanova(4), Seung Joon Baek(4), Nirmala B. Upadhyaya(4), Robert Dostal(4), C. Dees(3), Drew Meehan(3), Abbas E. Kitabchi(3), Pamela McKenzie(3), Johan Hartman(2)